Gregory A. Gould net worth and biography

Gregory Gould Biography and Net Worth

CFO of Aclarion

Mr. Gould has been Chief Financial Officer since September 2025 and brings extensive financial and operational leadership experience to Aclarion. He has raised more than $450 million in public company debt and equity offerings, led over ten acquisitions, successfully sold three publicly-traded companies, and guided three organizations through uplistings to Nasdaq.

Mr. Gould has a proven track record of building and streamlining accounting, finance, and administrative functions, with expertise spanning financial controllership, planning and analysis, compliance, consolidation, integration, and auditing. Prior to joining Aclarion, he served as CFO of Nanos Health, a pre-revenue pharmaceutical startup pioneering nanotechnology-based drug delivery solutions. He has also held CFO roles at 7 publicly-traded companies, including Charlotte’s Web (TSX: CWEB, OTC: CWBHF) and Aytu BioScience among others.

Mr. Gould received a Bachelor of Science in Business from the University of Colorado Boulder and is a Certified Public Accountant (CPA).

What is Gregory A. Gould's net worth?: The estimated net worth of Gregory A. Gould is at least $142.02 thousand as of August 14th, 2026. Gould owns 60,000 shares of Aclarion stock worth more than $142,020 as of October 8th. This net worth approximation does not reflect any other assets that Gould may own. Learn More about Gregory A. Gould's net worth.
How do I contact Gregory A. Gould?: The corporate mailing address for Gould and other Aclarion executives is 8181 Arista Place, Ste 100, Broomfield, CO, 80021. Aclarion can also be reached via phone at 833-275-2266. Learn More on Gregory A. Gould's contact information.
Has Gregory A. Gould been buying or selling shares of Aclarion?: Gregory A. Gould has not been actively trading shares of Aclarion over the course of the past ninety days. Most recently, on Friday, August 14th, Gregory A. Gould bought 10,000 shares of Aclarion stock. The stock was acquired at an average cost of $2.45 per share, with a total value of $24,500.00. Following the completion of the transaction, the chief financial officer now directly owns 60,000 shares of the company's stock, valued at $147,000. Learn More on Gregory A. Gould's trading history.
Who are Aclarion's active insiders?: Aclarion's insider roster includes Ryan Bond (Chief Strategy Officer), Scott Breidbart (Director), Gregory Gould (CFO), Gregory Gould (CFO), David Neal (Director), Brent Ness (CEO), Brent Ness (Chief Executive Officer, President, and Director), William Wesemann (Director), and Amanda Williams (Director). Learn More on Aclarion's active insiders.
Are insiders buying or selling shares of Aclarion?: During the last twelve months, Aclarion insiders bought shares 11 times. They purchased a total of 67,888 shares worth more than $176,647.43. The most recent insider tranaction occured on August, 17th when Director Amanda M Williams bought 5,857 shares worth more than $15,989.61. Insiders at Aclarion own 0.0% of the company. Learn More about insider trades at Aclarion.
Information on this page was last updated on 8/17/2026.

Gregory A. Gould Insider Trading History at Aclarion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/14/2026	Buy	10,000	$2.45	$24,500.00	60,000

Gregory A. Gould Buying and Selling Activity at Aclarion

Aclarion Company Overview

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Today's Range

Now: $2.35

$2.32

$2.41

50 Day Range

MA: $2.46

$2.02

$2.94

2 Week Range

Now: $2.35

$1.95

$12.03

Volume

21,449 shs

Average Volume

325,158 shs

Market Capitalization

$6.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2